X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Aventis Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs SANOFI INDIA - Comparison Results

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE SANOFI INDIA TTK HEALTHCARE/
SANOFI INDIA
 
P/E (TTM) x 21.7 39.9 54.5% View Chart
P/BV x 7.3 8.6 85.0% View Chart
Dividend Yield % 0.4 1.0 37.9%  

Financials

 TTK HEALTHCARE   SANOFI INDIA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
SANOFI INDIA
Dec-16
TTK HEALTHCARE/
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs6634,560 14.5%   
Low Rs3994,400 9.1%   
Sales per share (Unadj.) Rs535.61,028.5 52.1%  
Earnings per share (Unadj.) Rs15.9129.0 12.4%  
Cash flow per share (Unadj.) Rs20.0186.0 10.8%  
Dividends per share (Unadj.) Rs4.0068.00 5.9%  
Dividend yield (eoy) %0.81.5 49.6%  
Book value per share (Unadj.) Rs137.6753.6 18.3%  
Shares outstanding (eoy) m7.7723.03 33.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.04.4 22.8%   
Avg P/E ratio x33.334.7 95.9%  
P/CF ratio (eoy) x26.524.1 110.1%  
Price / Book Value ratio x3.95.9 64.9%  
Dividend payout %25.152.7 47.6%   
Avg Mkt Cap Rs m4,127103,174 4.0%   
No. of employees `0001.73.6 47.1%   
Total wages/salary Rs m6073,592 16.9%   
Avg. sales/employee Rs Th2,436.76,537.7 37.3%   
Avg. wages/employee Rs Th355.2991.4 35.8%   
Avg. net profit/employee Rs Th72.5819.8 8.8%   
INCOME DATA
Net Sales Rs m4,16223,686 17.6%  
Other income Rs m61708 8.6%   
Total revenues Rs m4,22324,394 17.3%   
Gross profit Rs m1975,281 3.7%  
Depreciation Rs m321,313 2.4%   
Interest Rs m3015 199.3%   
Profit before tax Rs m1974,661 4.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m731,691 4.3%   
Profit after tax Rs m1242,970 4.2%  
Gross profit margin %4.722.3 21.2%  
Effective tax rate %37.036.3 102.0%   
Net profit margin %3.012.5 23.7%  
BALANCE SHEET DATA
Current assets Rs m1,62915,673 10.4%   
Current liabilities Rs m1,0586,678 15.8%   
Net working cap to sales %13.738.0 36.1%  
Current ratio x1.52.3 65.6%  
Inventory Days Days3076 39.2%  
Debtors Days Days3422 150.5%  
Net fixed assets Rs m5568,098 6.9%   
Share capital Rs m78230 33.7%   
"Free" reserves Rs m87817,088 5.1%   
Net worth Rs m1,06917,356 6.2%   
Long term debt Rs m1590-   
Total assets Rs m2,39925,400 9.4%  
Interest coverage x7.6311.7 2.4%   
Debt to equity ratio x0.10-  
Sales to assets ratio x1.70.9 186.0%   
Return on assets %6.411.8 54.5%  
Return on equity %11.617.1 67.7%  
Return on capital %18.526.9 68.5%  
Exports to sales %0.824.5 3.2%   
Imports to sales %1.428.0 5.0%   
Exports (fob) Rs m335,801 0.6%   
Imports (cif) Rs m586,627 0.9%   
Fx inflow Rs m337,145 0.5%   
Fx outflow Rs m636,846 0.9%   
Net fx Rs m-30299 -10.1%   
CASH FLOW
From Operations Rs m1273,226 3.9%  
From Investments Rs m-146-1,555 9.4%  
From Financial Activity Rs m22-1,818 -1.2%  
Net Cashflow Rs m3-147 -1.7%  

Share Holding

Indian Promoters % 65.4 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 3.7 14.4 25.7%  
FIIs % 5.2 14.6 35.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 10.5 245.7%  
Shareholders   12,723 15,184 83.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  ASTRAZENECA PHARMA  PFIZER  

Compare TTK HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

TTK HEALTHCARE Announces Quarterly Results (1QFY19); Net Profit Down 276.0% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, TTK HEALTHCARE has posted a net profit of Rs 79 m (down 276.0% YoY). Sales on the other hand came in at Rs 2 bn (up 38.1% YoY). Read on for a complete analysis of TTK HEALTHCARE's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY19); Net Profit Up 35.1% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, SANOFI INDIA has posted a net profit of Rs 996 m (up 35.1% YoY). Sales on the other hand came in at Rs 7 bn (up 13.8% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Sep 21, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 5-YR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS